Clinical trialNCT03763929TerminatedPhase 2Interventional

Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke

SponsorDiffusion Pharmaceuticals IncEnrollment6Stroke, Acute

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will assess the potential efficacy and safety of TSC as early treatment for both ischemic and hemorrhagic stroke when administered while subject is in ambulance being transported to hospital.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrew Southerland, MD
University of Virginia
Principal Investigator
clinicaltrials.gov ↗
Jeffrey Saver, MD
University of California, Los Angeles
Study ChairKOL profile →
clinicaltrials.gov ↗
Karen Johnston, MD
University of Virginia
Study Chair
clinicaltrials.gov ↗
Nerses Sanossian, MD
University of Southern California
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, Los Angeles
Los Angeles, California, United States
University of Virginia
Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Trans-Sodium Crocetinate

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 22 Aug 2019
Primary completion: 19 Oct 2020
Completion: 19 Oct 2020
Last update posted: 18 Jun 2021
Registered enrollment: 6
Registry id: NCT03763929

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.